Overview
Qingyi Wei, MD, PhD, Professor in the Department of Medicine, is Associate Director for Cancer Control and Population Sciences, Co-leader of CCPS and Co-leader of Epidemiology and Population Genomics (Focus Area 1). He is a professor of Medicine and an internationally recognized epidemiologist focused on the molecular and genetic epidemiology of head and neck cancers, lung cancer, and melanoma. His research focuses on biomarkers and genetic determinants for the DNA repair deficient phenotype and variations in cell death. He is Editor-in-Chief of the open access journal "Cancer Medicine" and Associate Editor-in-Chief of the International Journal of Molecular Epidemiology and Genetics.
Area of Expertise: Epidemiology
Area of Expertise: Epidemiology
Current Appointments & Affiliations
Professor Emeritus in Population Health Sciences
·
2024 - Present
Population Health Sciences,
Basic Science Departments
Recent Publications
Gene-Level Analyses of Novel Olfactory-Related Signal from Severe SARS-CoV-2 GWAS Reveal Association with Disease Mortality.
Journal Article COVID · December 2025 IMPORTANCE: The coronavirus disease 2019 (COVID-19) was the third leading cause of mortality in the United States for three years in a row. The genetic contributions to disease severity remain unclear and many previously identified single nucleotide polymo ... Full text Link to item CiteGenome-wide association study of HBV-related hepatocellular carcinoma identifies a functional variant at the FAM114A1 locus.
Journal Article J Genet Genomics · November 13, 2025 Liver cancer ranks sixth in cancer incidence and third in cancer-related deaths worldwide. Hepatocellular carcinoma (HCC) is the primary histological subtype, and hepatitis B virus (HBV) carriers have a higher risk of HCC. Although several susceptibility l ... Full text Link to item CiteRural-urban disparities in cardiovascular and other competing risk of death among cancer patients.
Journal Article J Adv Res · October 10, 2025 INTRODUCTION: Rural-urban disparity of cancer is a major public health problem, with an unclear gap in noncancer death. It is important to evaluate rural-urban disparities in cardiovascular diseases (CVDs) and other competing death among cancer patients. O ... Full text Link to item CiteRecent Grants
Elucidating racial and ethnic differences in functional effects of the vaginal microbiome in ovarian cancer
ResearchAdvisor · Awarded by National Cancer Institute · 2024 - 2027A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
ResearchCollaborating Investigator · Awarded by Department of Defense · 2020 - 2025Postdoctoral Training in Genomic Medicine Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023View All Grants
Education
Johns Hopkins Unversity, Bloomberg School of Public Health ·
1993
Ph.D.
Nanjing Medical University (China) ·
1983
B.M.